247 related articles for article (PubMed ID: 37869238)
1. Update on Radiotherapy Changes of Nasopharyngeal Carcinoma Tumor Microenvironment.
Zhu DQ; Su C; Li JJ; Li AW; Luv Y; Fan Q
World J Oncol; 2023 Oct; 14(5):350-357. PubMed ID: 37869238
[TBL] [Abstract][Full Text] [Related]
2. Tumor Microenvironment as A "Game Changer" in Cancer Radiotherapy.
Jarosz-Biej M; Smolarczyk R; Cichoń T; Kułach N
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261963
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: correlation of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters with hypoxia-inducible factor 1α expression and tumor grade/stage.
Liu L; Hu L; Zeng Q; Peng D; Chen Z; Huang C; Liu Z; Wen Q; Zou F; Yan L
Ann Palliat Med; 2021 Feb; 10(2):2238-2253. PubMed ID: 33725777
[TBL] [Abstract][Full Text] [Related]
4. Role of HIF-1α in the Responses of Tumors to Radiotherapy and Chemotherapy.
Song CW; Kim H; Kim MS; Park HJ; Paek SH; Terezakis S; Cho LC
Cancer Res Treat; 2024 Jun; ():. PubMed ID: 38853541
[TBL] [Abstract][Full Text] [Related]
5. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
6. Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors.
Eckert F; Zwirner K; Boeke S; Thorwarth D; Zips D; Huber SM
Front Immunol; 2019; 10():407. PubMed ID: 30930892
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-Regulated Tumor-Derived Exosomes and Tumor Progression: A Focus on Immune Evasion.
Shao X; Hua S; Feng T; Ocansey DKW; Yin L
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233088
[TBL] [Abstract][Full Text] [Related]
8. The impact of hypoxia on immune state in cancer.
Mortezaee K; Majidpoor J
Life Sci; 2021 Dec; 286():120057. PubMed ID: 34662552
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
10. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
[TBL] [Abstract][Full Text] [Related]
12. Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment.
Zhang J; Fan J; Zeng X; Nie M; Luan J; Wang Y; Ju D; Yin K
Acta Pharm Sin B; 2021 Mar; 11(3):609-620. PubMed ID: 33777671
[TBL] [Abstract][Full Text] [Related]
13. The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications.
Tamura R; Tanaka T; Akasaki Y; Murayama Y; Yoshida K; Sasaki H
Med Oncol; 2019 Nov; 37(1):2. PubMed ID: 31713115
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products.
Lafta HA; AbdulHussein AH; Al-Shalah SAJ; Alnassar YS; Mohammed NM; Akram SM; Qasim MT; Najafi M
Curr Top Med Chem; 2023; 23(12):1104-1122. PubMed ID: 36722486
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the tumor microenvironment (TME) by melatonin.
Mu Q; Najafi M
Eur J Pharmacol; 2021 Sep; 907():174365. PubMed ID: 34302814
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional Nanoregulator Reshapes Immune Microenvironment and Enhances Immune Memory for Tumor Immunotherapy.
Yu M; Duan X; Cai Y; Zhang F; Jiang S; Han S; Shen J; Shuai X
Adv Sci (Weinh); 2019 Aug; 6(16):1900037. PubMed ID: 31453054
[TBL] [Abstract][Full Text] [Related]
17. PFC@O
Lan Z; Zou KL; Cui H; Chen H; Zhao YY; Yu GT
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675491
[TBL] [Abstract][Full Text] [Related]
18. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
[TBL] [Abstract][Full Text] [Related]
19. Combination antiangiogenic therapy and radiation in head and neck cancers.
Hsu HW; Wall NR; Hsueh CT; Kim S; Ferris RL; Chen CS; Mirshahidi S
Oral Oncol; 2014 Jan; 50(1):19-26. PubMed ID: 24269532
[TBL] [Abstract][Full Text] [Related]
20. Effect of HIF-1αsiRNA-linked AuNRs on radiotherapy of nasopharyngeal carcinoma.
Xu G; Zhang H; Li Z; Wu S; Quan R; Mao K; Sheng Y; Li X
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):185-190. PubMed ID: 33040834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
